Drug Shortage Report for ESOMEPRAZOLE
Report ID | 171344 |
Drug Identification Number | 02520702 |
Brand name | ESOMEPRAZOLE |
Common or Proper name | Esomeprazole Magnesium Delayed Release Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE |
Strength(s) | 40MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-10-07 |
Estimated end date | 2022-11-10 |
Actual end date | 2022-10-13 |
Shortage status | Resolved |
Updated date | 2022-10-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-10-15 | French | Compare |
v4 | 2022-10-15 | English | Compare |
v3 | 2022-10-08 | English | Compare |
v2 | 2022-10-07 | French | Compare |
v1 | 2022-10-07 | English | Compare |
Showing 1 to 5 of 5